Nelson Sonja
- SEC CIK
- 0001674905
No open-market purchases or sales filed in the past year.
Current role at each company
- MOTS Motus GI Holdings, Inc.Directoras of Mar 13, 2024
- AMAM Ambrx Biopharma, Inc.Chief Financial Officeras of Mar 7, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nelson Sonja as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AMAM Ambrx Biopharma, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2023 (view filing) | Oct 27 | 4 days | Nelson SonjaChief Financial Officer | SSale | −12.8K | $9.82 | −$125.5K | −8.9%130.1K after | 10b5-1 |